Literature DB >> 9541115

Identification of a new missense mutation in MyBP-C associated with hypertrophic cardiomyopathy.

J C Moolman-Smook1, B Mayosi, P Brink, V A Corfield.   

Abstract

Hypertrophic cardiomyopathy is a primary cardiac disease, characterised by idiopathic myocardial hypertrophy, and is caused by defects in sarcomeric protein encoding genes. One of these genes is cardiac myosin binding protein C (MyBP-C), in which a number of splice site and duplication mutations causing HCM have been described. During mutation screening of a South African HCM population by PCR-SSCP, a missense mutation, Arg654His, was detected in one proband. Although the mutation was present in his three adult children, only the proband himself was markedly affected. This is the first report of a disease associated missense mutation in MyBP-C which does not affect the myosin or titin binding domains.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9541115      PMCID: PMC1051254          DOI: 10.1136/jmg.35.3.253

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  11 in total

1.  Identification of a new missense mutation at Arg403, a CpG mutation hotspot, in exon 13 of the beta-myosin heavy chain gene in hypertrophic cardiomyopathy.

Authors:  J C Moolman; P A Brink; V A Corfield
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

Review 2.  Sudden death from cardiac causes in children and young adults.

Authors:  R R Liberthson
Journal:  N Engl J Med       Date:  1996-04-18       Impact factor: 91.245

3.  Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle.

Authors:  K Poetter; H Jiang; S Hassanzadeh; S R Master; A Chang; M C Dalakas; I Rayment; J R Sellers; L Fananapazir; N D Epstein
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

4.  Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.

Authors:  L Thierfelder; H Watkins; C MacRae; R Lamas; W McKenna; H P Vosberg; J G Seidman; C E Seidman
Journal:  Cell       Date:  1994-06-03       Impact factor: 41.582

5.  Clinical and prognostic evaluation of familial hypertrophic cardiomyopathy in two South African families with different cardiac beta myosin heavy chain gene mutations.

Authors:  B M Posen; J C Moolman; V A Corfield; P A Brink
Journal:  Br Heart J       Date:  1995-07

Review 6.  Contractile protein mutations and heart disease.

Authors:  K L Vikstrom; L A Leinwand
Journal:  Curr Opin Cell Biol       Date:  1996-02       Impact factor: 8.382

7.  A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy.

Authors:  A Freiburg; M Gautel
Journal:  Eur J Biochem       Date:  1996-01-15

8.  Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy.

Authors:  G Bonne; L Carrier; J Bercovici; C Cruaud; P Richard; B Hainque; M Gautel; S Labeit; M James; J Beckmann; J Weissenbach; H P Vosberg; M Fiszman; M Komajda; K Schwartz
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

9.  The major myosin-binding domain of skeletal muscle MyBP-C (C protein) resides in the COOH-terminal, immunoglobulin C2 motif.

Authors:  T Okagaki; F E Weber; D A Fischman; K T Vaughan; T Mikawa; F C Reinach
Journal:  J Cell Biol       Date:  1993-11       Impact factor: 10.539

10.  Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modulator of cardiac contraction?

Authors:  M Gautel; O Zuffardi; A Freiburg; S Labeit
Journal:  EMBO J       Date:  1995-05-01       Impact factor: 11.598

View more
  6 in total

Review 1.  Genetics of inherited cardiomyopathies in Africa.

Authors:  Gasnat Shaboodien; Timothy F Spracklen; Stephen Kamuli; Polycarp Ndibangwi; Carla Van Niekerk; Ntobeko A B Ntusi
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

2.  The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events.

Authors:  J C Moolman-Smook; W J De Lange; E C Bruwer; P A Brink; V A Corfield
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

3.  A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy.

Authors:  Q Yang; A Sanbe; H Osinska; T E Hewett; R Klevitsky; J Robbins
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

4.  Molecular autopsy in maternal-fetal medicine.

Authors:  Hanan E Shamseldin; Wesam Kurdi; Fatima Almusafri; Maha Alnemer; Alya Alkaff; Zeneb Babay; Amal Alhashem; Maha Tulbah; Nada Alsahan; Rubina Khan; Bahauddin Sallout; Elham Al Mardawi; Mohamed Zain Seidahmed; Niema Meriki; Yasser Alsaber; Alya Qari; Ola Khalifa; Wafaa Eyaid; Zuhair Rahbeeni; Ahmed Kurdi; Mais Hashem; Tarfa Alshidi; Eman Al-Obeid; Firdous Abdulwahab; Niema Ibrahim; Nour Ewida; Karen El-Akouri; Mariam Al Mulla; Tawfeg Ben-Omran; Matthias Pergande; Sebahattin Cirak; Saeed Al Tala; Ranad Shaheen; Eissa Faqeih; Fowzan S Alkuraya
Journal:  Genet Med       Date:  2017-07-20       Impact factor: 8.822

Review 5.  Mendelian-inherited heart disease: a gateway to understanding mechanisms in heart disease Update on work done at the University of Stellenbosch.

Authors:  P A Brink; J C Moolman-Smook; V A Corfield
Journal:  Cardiovasc J Afr       Date:  2009 Jan-Feb       Impact factor: 1.167

6.  Long-term follow-up of R403WMYH7 and R92WTNNT2 HCM families: mutations determine left ventricular dimensions but not wall thickness during disease progression.

Authors:  Miriam Revera; Lize Van der Merwe; Marshall Heradien; Althea Goosen; Valerie A Corfield; Paul A Brink; Johanna C Moolman-Smook
Journal:  Cardiovasc J Afr       Date:  2007 May-Jun       Impact factor: 1.167

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.